1
|
Rivero P, Ivanova V, Barril X, Casampere M, Casas J, Fabriàs G, Díaz Y, Matheu MI. Targeting dihydroceramide desaturase 1 (Des1): Syntheses of ceramide analogues with a rigid scaffold, inhibitory assays, and AlphaFold2-assisted structural insights reveal cyclopropenone PR280 as a potent inhibitor. Bioorg Chem 2024; 145:107233. [PMID: 38422591 DOI: 10.1016/j.bioorg.2024.107233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Revised: 01/04/2024] [Accepted: 02/19/2024] [Indexed: 03/02/2024]
Abstract
Dihydroceramide desaturase 1 (Des1) catalyzes the formation of a CC double bond in dihydroceramide to furnish ceramide. Inhibition of Des1 is related to cell cycle arrest and programmed cell death. The lack of the Des1 crystalline structure, as well as that of a close homologue, hampers the detailed understanding of its inhibition mechanism and difficults the design of new inhibitors, thus making Des1 a strategic target. Based on previous structure-activity studies, different ceramides containing rigid scaffolds were designed. The synthesis and evaluation of these compounds as Des1 inhibitors allowed the identification of PR280 as a better Des 1 inhibitor in vitro (IC50 = 700 nM) than GT11 and XM462, the current reference inhibitors. This cyclopropenone ceramide was obtained in a 6-step synthesis with a 24 % overall yield. The highly confident 3D structure of Des1, recently predicted by AlphaFold2, served as the basis for conducting docking studies of known Des1 inhibitors and the ceramide derivatives synthesized by us in this study. For this purpose, a complete holoprotein structure was previously constructed. This study has allowed a better knowledge of key ligand-enzyme interactions for Des1 inhibitory activity. Furthermore, it sheds some light on the inhibition mechanism of GT11.
Collapse
Affiliation(s)
- Pablo Rivero
- Universitat Rovira i Virgili, Departament de Química Analítica i Química Orgànica, Faculty of Chemistry, C/Marcel.lí Domingo 1, Tarragona 43007, Spain
| | - Varbina Ivanova
- Universitat de Barcelona, Department of Physical Chemistry, Faculty of Pharmacy, Av. Joan XXIII s/n, Barcelona 08028, Spain
| | - Xavier Barril
- Universitat de Barcelona, Department of Physical Chemistry, Faculty of Pharmacy, Av. Joan XXIII s/n, Barcelona 08028, Spain
| | - Mireia Casampere
- Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Department of Biological Chemistry, C/Jordi Girona 18-26, Barcelona 08034, Spain
| | - Josefina Casas
- Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Department of Biological Chemistry, C/Jordi Girona 18-26, Barcelona 08034, Spain
| | - Gemma Fabriàs
- Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Department of Biological Chemistry, C/Jordi Girona 18-26, Barcelona 08034, Spain
| | - Yolanda Díaz
- Universitat Rovira i Virgili, Departament de Química Analítica i Química Orgànica, Faculty of Chemistry, C/Marcel.lí Domingo 1, Tarragona 43007, Spain.
| | - M Isabel Matheu
- Universitat Rovira i Virgili, Departament de Química Analítica i Química Orgànica, Faculty of Chemistry, C/Marcel.lí Domingo 1, Tarragona 43007, Spain.
| |
Collapse
|
2
|
Radkowski K, Fürstner A. A Sphingolipid Fatty Acid Constituent Made by Alkyne trans‐Hydrogenation: Total Synthesis of Symbioramide. Adv Synth Catal 2022. [DOI: 10.1002/adsc.202200540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|